Advanced search
Publication Cover
Modern Rheumatology Volume 31, 2021 - Issue 2
Journal homepage
150
Views
2
CrossRef citations to date
0
Altmetric
Rapid Communications

Adherence to denosumab for the treatment of osteoporosis in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study

Masanori Nakayamaa Department of Orthopaedic Surgery, School of Medicine, International University of Health and Welfare (IUHW), Chiba, Japan
,
Takefumi Furuyab Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7771-2813
ORCID Icon,
Eisuke Inoueb Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;c Showa University Research Administration Center, Showa University, Tokyo, Japan
,
Eiichi Tanakab Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan
,
Katsunori Ikarid Department of Orthopedic Surgery, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan
,
Atsuo Taniguchib Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan
,
Hisashi Yamanakab Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;e Rheumatology, Sanno Medical Center, Tokyo, Japan
&
Masayoshi Harigaib Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan
 show all
Pages 510-513 | Received 30 Jan 2020, Accepted 18 Jun 2020, Published online: 15 Jul 2020

References

  • Haugeberg G, Ørstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum. 2002;46(7):1720–8.
  • Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A, et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64(12):1871–8.
  • Takeuchi T, Tanaka Y, Ishiguro N, Yamanaka H, Yoneda T, Ohira T, et al. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Ann Rheum Dis. 2016;75(6):983–90.
  • Fahrleitner-Pammer A, Papaioannou N, Gielen E, Feudjo Tepie M, Toffis C, Frieling I, et al. Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Arch Osteoporos. 2017;12(1):58.
  • Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S, et al. Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int. 2012;23(1):317–26.
  • Park JH, Park EK, Koo DW, Lee S, Lee SH, Kim GT, Lee SG. Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2017;18(1):152.
  • Suzuki T, Nakamura Y, Kamimura M, Ikegami S, Uchiyama S, Kato H. Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis. Osteoporos Sarcopenia. 2017;3(2):108–11.
  • Matsuno H. Assessment of distal radius bone mineral density in osteoporosis patients receiving denosumab, including those with rheumatoid arthritis and those receiving oral glucocorticoids. Drugs RD. 2016;16(4):347–53.
  • Ishida O, Furuya T, Inoue E, Ochi K, Ikari K, Taniguchi A, et al. Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: results from a large prospective observational cohort study. Mod Rheumatol. 2015;25(3):373–8.
  • Ochi K, Furuya T, Ikari K, Taniguchi A, Yamanaka H, Momohara S. Association between serum vitamin D level and history of falls in elderly Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(3):460–2.
  • Furuya T, Hosoi T, Tanaka E, Nakajima A, Taniguchi A, Momohara S, et al. Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin Rheumatol. 2013;32(7):1081–7.
  • Nakayama M, Furuya T, Inoue E, Tanaka E, Ikari K, Nakajima A, et al. Factors associated with decreasing serum 25(OH)D among Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Mod Rheumatol. 2019;29(3):430–5.
  • Yamanaka H, Tanaka E, Nakajima A, Furuya T, Ikari K, Taniguchi A, et al. A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today's treatment options. Mod Rheumatol. 2020;30(1):1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.